The Khyber Pakhtunkhwa government has introduced the Khyber Pakhtunkhwa Drug Amendment Bill 2026 in the provincial assembly, proposing stricter penalties for the sale of counterfeit, adulterated, unregistered, and unlicensed medicines.

Under the proposed bill, selling unregistered or unlicensed medicines could result in up to 10 years in prison and a fine of up to Rs100 million, while selling counterfeit or adulterated medicines could carry a sentence of up to seven years and a fine of up to Rs50 million.

According to the bill, a fine of Rs200 million would be imposed for continuing to sell unregistered medicines despite a conviction. Selling a medicine under a false name could result in up to 10 years in prison and a fine of Rs150 million.

Also Read : KP Launches Pakistan’s First Sub-National Disaster Risk Reduction Policy

The proposed legislation also recommends up to one year in prison and a fine of Rs10 million for obstructing a drug inspector in the performance of their duties. Violating three rules under the Drug Act could result in up to five years in prison and a fine of Rs10 million.

The bill further proposes that the Quality Control Board be authorized to send medicines abroad for laboratory analysis.

It also proposes that the position of Special Drug Chairman be accorded a status equivalent to that of a High Court judge.